Adora Risk Identification of Tricyclic Antidepresant

Abstract

Objective:Tricyclic antidepressant (TCA) poisonings can cause serious clinical outcome. The Antidepressant OverdoseRisk Assessment (ADORA) criteria are used in the assessment of patients with TCA poisoning. However, the data about the benefits of these criteria in the clinical practice are insufficient to validate the ADORA criteria. The aim of this study was to determine the relationship of ADORA criteria with clinical outcome. Materials and Methods:A total of 133 patients who admitted only with TCA poisoning at a university hospital emergency department. The patients were divided into high risk and low risk groups according to ADORA criteria. Results: The mean age was 25 (range 18-55) years. Patients commonly used amitryptiline as TCA agent. Most common symptoms were dry skin, emesis and mydriasis. According to risk classification; 59.4% of the patients were in high risk group. The most common sight finding was the right axis deviation and the AVR was the R> S finding. According to ADORA's opinion, 79 patients (n = 59.4%) were high-risk carriers. The patients were discharged without any complications. As the number of ADORA positive risk scores increased, the length of hospitalization, QTc height and seizure frequency increased. Conclusion: TheADORA criteria is useful in assessment and clinical follow-up of TCA poisoning.

Keywords

• tricyclic antidepressants,poisoning,The Antidepressant Overdose Risk Assessment

Trisiklik Antidepresan Zehirlenmelerinde Adora Risk Skorlaması

Abstract

Amaç: Trisiklik antidepresan (TSA) zehirlenmeleri ciddi klinik sonuçlara neden olabilir. TCA zehirlenmesi olan hastaların değerlendirilmesinde “Antidepresan Doz Aşımı Risk Değerlendirmesi” (ADORA) kriterleri kullanılmıştır. Bununla birlikte, bu kriterlerin klinik uygulamadaki yararları hakkındaki veriler, ADORA kriterlerini doğrulamak için yetersizdir. Bu çalışmanın amacı, ADORA kriterlerinin klinik sonuç ile ilişkisini belirlemektir. Gereç ve Yöntem: Çalışmaya yıllık toplam 133 hasta dahil edildi. Hastalar ADORA kriterlerine göre yüksek risk ve düşük risk gruplarına ayrıldı. Bulgular:Ortanca yaş 25 (18-55 yaş aralığında) idi. Hastalar genellikle TCA ajanı olarak amitriptilin kullanmışlardır. En sık görülen semptomlar kuru deri, kusma ve midriyazis idi. Risk sınıflandırmasına göre; Hastaların %59.4'ü yüksek risk grubunda idi. En sık görülen bulgular sağ aks sapması ve aVR de R>S bulgusu idi. ADORA kriterlerine göre 79 hasta (n=%59,4) yüksek risk grubunda idi. Hastaların tümü komplikasyonsuz taburcu edilmişti. ADORA pozitif risk skor sayısı arttıkça yatış süresi, QTc uzunluğu ve nöbet sıklığı artmaktaydı.Sonuç:ADORA kriterleri, TCA zehirlenmesinin değerlendirilmesi ve klinik takibinde faydalıdır.

Keywords

• trisiklik antidepresanlar,zehirlenme,Antidepresan Aşırı Doz Risk Değerlendirmesi

References

1. 1. Watson WA, Litovitz TL, Klein-Schwartz W, Rodgers GC, Jr., Youniss J, Reid N, et al. 2003 annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. The American journal of emergency medicine. 2004;22(5):335-404.
2. 2. Woolf AD, Erdman AR, Nelson LS, Caravati EM, Cobaugh DJ, Booze LL, et al. Tricyclic antidepressant poisoning: an evidence-based consensus guideline for out-of-hospital management. Clin Toxicol (Phila). 2007;45(3):203-33.
3. 3. Foulke GE. Identifying toxicity risk early after antidepressant overdose. The American journal of emergency medicine. 1995;13(2):123-6.
4. 4. Bazett HC. An analysis of the time relationsof electrocardiograms. Heart. 1920;7:353-70.
5. 5. Unverir P, Atilla R, Karcioglu O, Topacoglu H, Demiral Y, Tuncok Y. A retrospective analysis of antidepressant poisonings in the emergency department: 11-year experience. Human & experimental toxicology. 2006;25(10):605-12.
6. 6. Liebelt EL, Francis PD, Woolf AD. ECG lead aVR versus QRS interval in predicting seizures and arrhythmias in acute tricyclic antidepressant toxicity. Annals of emergency medicine. 1995;26(2):195-201.
7. 7. Foulke GE, Albertson TE. QRS interval in tricyclic antidepressant overdosage: inaccuracy as a toxicity indicator in emergency settings. Annals of emergency medicine. 1987;16(2):160-3.
8. 8. Biggs JT, Spiker DG, Petit JM, Ziegler VE. Tricyclic antidepressant overdose: incidence of symptoms. Jama. 1977;238(2):135-8.

9. 9. Caravati EM, Bossart PJ. Demographic and electrocardiographic factors associated with severe tricyclic antidepressant toxicity. Journal of Toxicology: Clinical Toxicology. 1991;29(1):31-43.
10. 10. Miura N, Saito T, Taira T, Umebachi R, Inokuchi S. Risk factors for QT prolongation associated with acute psychotropic drug overdose. The American journal of emergency medicine. 2015;33(2):142-9.
11. 11. Koegelenberg CF, Joubert ZJ, Irusen EM. Tricyclic antidepressant overdose necessitating ICU admission. South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde. 2012;102(5):293-4.
12. 12. Eyer F, Stenzel J, Schuster T, Felgenhauer N, Pfab R, von Bary C, et al. Risk assessment of severe tricyclic antidepressant overdose. Human & experimental toxicology. 2009;28(8):511-9.
13. 13. Waring WS. Clinical use of antidepressant therapy and associated cardiovascular risk. Drug, healthcare and patient safety. 2012;4:93-101.
14. 14. Paksu S, Duran L, Altuntas M, Zengin H, Salis O, Ozsevik SN, et al. Amitriptyline overdose in emergency department of university hospital: evaluation of 250 patients. Human & experimental toxicology. 2014;33(9):980-90.
15. 15. Glancy DL. ECG Of the Month: Suicide. The Journal of the Louisiana State Medical Society : official organ of the Louisiana State Medical Society. 2016;168(2):66-7.
16. 16. Abeyaratne DD, Liyanapathirana C, Gamage A, Karunarathne P, Botheju M, Indrakumar J. Survival after severe amitriptyline poisoning with prolonged ventricular tachycardia and cardiac arrest. BMC research notes. 2016;9:167.